Compass Therapeutics (CMPX)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from CMPX's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Compass Therapeutics's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $0 | $850,000 | $0 |
| Net income | -$82M | -$39M | -$42M | -$49M | -$66M |
| Free cash flow | -$21M | -$34M | -$41M | -$45M | -$49M |
| EPS (diluted) | -$1.31 | -$0.37 | -$0.33 | -$0.36 | -$0.42 |
| Operating margin | — | — | — | -6661.8% | — |
Superinvestors who own CMPX
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | $8M | 0.00% | Q2 2026 |
Insider buying
Open-market purchases by Compass Therapeutics's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Neil Lerner Chief Accounting Officer |
20,000 | $0.92 | $18,400 |
| Sep 24, 2026 | Neil Lerner Chief Accounting Officer |
2,500 | $1.14 | $2,850 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when CMPX trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Compass Therapeutics insiders buying the stock?
2 open-market insider purchases of CMPX in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Compass Therapeutics?
1 of the superinvestors Investingly tracks hold CMPX in their latest 13F, including Cliff Asness.
Companies like Compass Therapeutics
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 8, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.